Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Hope for new psoriasis treatment
Fri October 30th - A possible new therapy for psoriasis has shown promise, a European conference has heard. More
Shop workers' risk of getting COVID-19
Fri October 30th - Customer-facing shop staff are about five times more likely to test positive for COVID-19 than their colleagues in other positions, a small American study has found. More
CA125 test better at predicting ovarian cancer
Fri October 30th - A readily available blood test is able to predict ovarian cancer risk more successfully than previously thought – particularly for the over 50s, according to newly published findings. More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...

Joint replacement report shows “continued success”

Wednesday September 16th 2020

An annual report has been released showing the outcomes of joint replacement procedures.

The report was published yesterday (15 September) by the National Joint Registry, and covers England, Wales, Northern Ireland, the Isle of Man and the States of Guernsey.

Its authors state that there have been “continued successful outcomes” for hip, knee, ankle, elbow and shoulder joint replacements.

The number of joint replacements is continually rising, with just under a quarter of a million records submitted to the registry in 2019.

It shows that 90% of hip replacements and 98% of knee replacements were to treat osteoarthritis.

Greater numbers of these operations were carried out in women than men, which is in line with the rise in cases of osteoarthritis in women.

The authors also add that most hip or knee replacements in patients over the age of 75 will last for the rest of their lives.

Medical director of the registry, Mr Tim Wilton, said: “The National Joint Registry is the largest and most comprehensive national audit of joint replacement surgery in the world. The data in this report enables multiple stakeholders, the most important being patients, to see the outcome performance of implants and consider patient-related factors that influence outcome.”

He gave thanks to all joint replacement patients who allowed their procedure details to be recorded, “which provides data for the important analysis contained in the report. This in turn enables a more informed decision-making process for future joint replacement patients and also serves to improve performance outcomes.”

The report was launched at the British Orthopaedic Association’s Online Congress.

Tags: NHS | Orthopaedics | Rheumatology | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)